$93.60
-0.32-0.34%
Dern. MÀJ: Nov 13, 1:04 PM
CRH fell 15.5% from $111.16 to $93.92, behind the S&P 500's +12.7%. Its worst day was May 19 (−4.7%), and its low came Oct 14 at $79.20.
Story events cover the past 12 months · Times ET
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CRH shares rose 5.9%, while the S&P 500 fell 0.3%.
+5.9% · S&P 500 −0.3%
CRH closed at its highest level of the year, 18.2% above where the year started.
+5.4% · S&P 500 +0.7%
EPS of $1.52 missed the $1.53 estimate on $9.4B revenue (est. $9.5B); FY EPS guidance of $5.60–$6.05 against the $6.09 consensus.
+0.6% · S&P 500 −0.3%
CRH shares rose 7.5%, while the S&P 500 rose 2.5%.
+7.5%, the year's best day · S&P 500 +2.5%
EPS of $-0.20 beat the $-0.22 estimate on $7.4B revenue (est. $7.1B); FY EPS guidance of $5.60–$6.05 against the $5.93 consensus.
+4.4% · S&P 500 +1.0%
EPS of $2.21 beat the $2.03 estimate on $10.8B revenue (est. $10.7B); FY EPS guidance of $5.60–$6.05 against the $5.95 consensus.
−3.7% · S&P 500 +1.7%
CRH closed at its lowest level of the year, 28.8% below where the year started.
−1.2% · S&P 500 −1.1%
EPS of $2.09 beat the $2.05 estimate on $11.4B revenue (est. $11.6B); FY EPS guidance of $5.37–$5.59 against the $5.62 consensus.
+4.7% · S&P 500 −0.4%
Where it ended: a close of $93.92 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 17, 2027 (EPS est. $1.35, revenue est. $10.0B).